Literature DB >> 8764295

Impaired ventilatory responses to hypoxia and hypercapnia in mutant mice deficient in endothelin-1.

T Kuwaki1, W H Cao, Y Kurihara, H Kurihara, G Y Ling, M Onodera, K H Ju, Y Yazaki, M Kumada.   

Abstract

We studied respiratory functions in mutant mice deficient in endothelin-1 (ET-1) generated by gene targeting. In conscious adult mice heterozygous for ET-1 gene mutation (ET+/- heterozygous mice), arterial PO2 was significantly lower, PCO2 tended to be higher, and pH tended to be lower than in wild-type littermates. When these conscious mice breathed room air, respiratory minute volume and rate, determined by body plethysmography, were not significantly different between the two groups. However, when ET+/- heterozygous mice were subjected to systemic hypoxia (1:1 air-N2) or hypercapnia (5% CO2-95% O2), increases in respiratory minute volume were significantly attenuated. In conscious newborn ET-/- homozygous mice delivered by cesarean section and tracheotomized, ventilatory responses to systemic hypoxia and hypercapnia, regularly observed in newborn wild-type mice, were almost totally absent. In urethan-anesthetized adult ET+/- heterozygous mice, increases in phrenic nerve discharges in response to hypoxia and hypercapnia were significantly attenuated. Our results demonstrate that ventilatory responses to hypoxia and hypercapnia are impaired in ET-1-deficient mice and suggest that endogenous ET-1 participates in the physiological control of ventilation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8764295     DOI: 10.1152/ajpregu.1996.270.6.R1279

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

1.  A candidate gene study of obstructive sleep apnea in European Americans and African Americans.

Authors:  Emma K Larkin; Sanjay R Patel; Robert J Goodloe; Yali Li; Xiaofeng Zhu; Courtney Gray-McGuire; Mark D Adams; Susan Redline
Journal:  Am J Respir Crit Care Med       Date:  2010-06-10       Impact factor: 21.405

Review 2.  Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2.

Authors:  Nanduri R Prabhakar; Gregg L Semenza
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

3.  Systems biology analyses of gene expression and genome wide association study data in obstructive sleep apnea.

Authors:  Yu Liu; Sanjay Patel; Rod Nibbe; Sean Maxwell; Salim A Chowdhury; Mehmet Koyuturk; Xiaofeng Zhu; Emma K Larkin; Sarah G Buxbaum; Naresh M Punjabi; Sina A Gharib; Susan Redline; Mark R Chance
Journal:  Pac Symp Biocomput       Date:  2011

4.  Systemic hypertension induced by hepatic overexpression of human preproendothelin-1 in rats.

Authors:  V Niranjan; S Télémaque; D deWit; R D Gerard; M Yanagisawa
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

5.  Molecular analysis of congenital central hypoventilation syndrome.

Authors:  Ayako Sasaki; Masayo Kanai; Kazuki Kijima; Kazuhiro Akaba; Motoya Hashimoto; Hisaya Hasegawa; Shinsuke Otaki; Takenobu Koizumi; Satoshi Kusuda; Youhei Ogawa; Keiji Tuchiya; Wakako Yamamoto; Tomohiko Nakamura; Kiyoshi Hayasaka
Journal:  Hum Genet       Date:  2003-10-18       Impact factor: 4.132

Review 6.  HIF-1 and ventilatory acclimatization to chronic hypoxia.

Authors:  Frank L Powell; Zhenxing Fu
Journal:  Respir Physiol Neurobiol       Date:  2008-12-10       Impact factor: 1.931

7.  Pbx3 deficiency results in central hypoventilation.

Authors:  Joon Whan Rhee; Akiko Arata; Licia Selleri; Yakop Jacobs; Satoru Arata; Hiroshi Onimaru; Michael L Cleary
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

Review 8.  Endothelin.

Authors:  Anthony P Davenport; Kelly A Hyndman; Neeraj Dhaun; Christopher Southan; Donald E Kohan; Jennifer S Pollock; David M Pollock; David J Webb; Janet J Maguire
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

9.  Pathophysiology of the endothelin system - lessons from genetically manipulated animal models.

Authors:  K von Websky; S Heiden; T Pfab; Berthold Hocher
Journal:  Eur J Med Res       Date:  2009-01-28       Impact factor: 2.175

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.